|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM386428654 |
003 |
DE-627 |
005 |
20250509095124.0 |
007 |
cr uuu---uuuuu |
008 |
250508s2025 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.202505455
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1361.xml
|
035 |
|
|
|a (DE-627)NLM386428654
|
035 |
|
|
|a (NLM)40166856
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Lu, Mei
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Correction to "Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer Immunotherapy"
|
264 |
|
1 |
|c 2025
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Revised 01.04.2025
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a ErratumFor: Adv Mater. 2022 Sep;34(35):e2204765. doi: 10.1002/adma.202204765.. - PMID 35793475
|
500 |
|
|
|a Citation Status Publisher
|
650 |
|
4 |
|a Published Erratum
|
700 |
1 |
|
|a Xing, Haonan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shao, Wanxuan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Tian
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Mengjie
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Yongchao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Fangzhou
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Weng, Yuhua
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zheng, Aiping
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Yuanyu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liang, Xing-Jie
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g (2025) vom: 01. Apr., Seite e2505455
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnas
|
773 |
1 |
8 |
|g year:2025
|g day:01
|g month:04
|g pages:e2505455
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202505455
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|j 2025
|b 01
|c 04
|h e2505455
|